Medistem, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2005-01-01
- Employees
- 5
- Market Cap
- -
- Website
- http://medisteminc.com
Phase I/II Trial of Endometrial Regenerative Cells (ERC) in Patients With Critical Limb Ischemia
Phase 1
- Conditions
- Peripheral Vascular Diseases
- Interventions
- Biological: Administration of ERC
- First Posted Date
- 2012-03-20
- Last Posted Date
- 2012-03-20
- Lead Sponsor
- Medistem Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT01558908
- Locations
- 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
© Copyright 2025. All Rights Reserved by MedPath